Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms)*: Fundamentals and Salient Clinical Practice Points for Medical Oncologists

dc.contributor.authorBasu, Sandip
dc.contributor.authorParghane, R.
dc.contributor.authorRanade, R.
dc.contributor.authorThapa, P.
dc.date.accessioned2020-10-05T09:14:54Z
dc.date.available2020-10-05T09:14:54Z
dc.date.issued2019
dc.description.divisionRMCen
dc.format.extent4893 bytes
dc.format.mimetypetext/html
dc.identifier.sourceIndian Journal of Medical and Paediatric Oncology, 2019. Vol. 40 (2): pp. 165-171en
dc.identifier.urihttp://hdl.handle.net/123456789/20737
dc.language.isoenen
dc.subjectNeuroendocrine tumoren
dc.subjectneuroendocrine neoplasmen
dc.subjectpeptide receptor radionuclide therapy (PRRT)en
dc.subjectSomatostatin receptor imagingen
dc.subject68Ga-DOTATATE PET-CTen
dc.subject99mTc-HYNIC-TOC SPECTen
dc.subjectFDG-PET/CTen
dc.subject177Lu-DOTATATEen
dc.subject90Y-DOTATOCen
dc.titlePeptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms)*: Fundamentals and Salient Clinical Practice Points for Medical Oncologistsen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0822.htm
Size:
4.78 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections